| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.652 | 0.012 | 0.653 | Toll-Like receptor 7 agonist | 0.653 0.012 CID_154699790 0.653 0.012 CID_154699791 | CID_154699791 | |
| 0.647 | 0.012 | 0.647 | Toll-Like receptor agonist | 0.647 0.012 CID_154699790 0.647 0.012 CID_154699791 | ||
| 0.524 | 0.005 | 0.524 | Phosphodiesterase inhibitor | 0.453 0.005 CID_154699790 0.453 0.005 CID_154699791 | ||
| 0.393 | 0.018 | 0.432 | Cyclic AMP phosphodiesterase inhibitor | 0.432 0.013 CID_154699790 0.432 0.013 CID_154699791 | CID_154699791 | |
| 0.403 | 0.028 | 0.479 | Cardiotonic | 0.479 0.018 CID_154699790 0.479 0.018 CID_154699791 | CID_154699791 | |
| 0.356 | 0.004 | 0.447 | Phosphodiesterase IV inhibitor | 0.447 0.004 CID_154699790 0.447 0.004 CID_154699791 | CID_154699791 | |
| 0.318 | 0.022 | 0.318 | Gastrin inhibitor | 0.304 0.03 CID_154699790 0.304 0.03 CID_154699791 | ||
| 0.305 | 0.012 | 0.305 | Insulin secretagoues | 0.295 0.013 CID_154699790 0.295 0.013 CID_154699791 | ||
| 0.301 | 0.009 | 0.349 | Bronchodilator | 0.349 0.007 CID_154699790 0.349 0.007 CID_154699791 | CID_154699791 | |
| 0.294 | 0.011 | 0.294 | TRKB antagonist | 0.2 0.025 CID_154699790 0.2 0.025 CID_154699791 | ||
| 0.25 | 0.007 | 0.25 | Phosphodiesterase I inhibitor | 0.139 0.02 CID_154699790 0.139 0.02 CID_154699791 | ||
| 0.312 | 0.069 | 0.312 | Nootropic | 0.234 0.122 CID_154699790 0.234 0.122 CID_154699791 | ||
| 0.229 | 0.005 | 0.229 | Phosphodiesterase 5A inhibitor | 0.153 0.01 CID_154699790 0.153 0.01 CID_154699791 | ||
| 0.22 | 0.005 | 0.22 | Phosphodiesterase V inhibitor | 0.144 0.012 CID_154699790 0.144 0.012 CID_154699791 | ||
| 0.202 | 0.005 | 0.202 | Phosphodiesterase 1B inhibitor | 0.088 0.019 CID_154699790 0.088 0.019 CID_154699791 | ||
| 0.196 | 0.006 | 0.196 | Phosphodiesterase III inhibitor | 0.125 0.014 CID_154699790 0.125 0.014 CID_154699791 | ||
| 0.19 | 0.018 | 0.19 | 5 Hydroxytryptamine 3A agonist | |||
| 0.183 | 0.013 | 0.21 | Adenosine A1 receptor antagonist | 0.21 0.01 CID_154699790 0.21 0.01 CID_154699791 | CID_154699791 | |
| 0.228 | 0.066 | 0.228 | Anticonvulsant | 0.149 0.131 CID_154699790 0.149 0.131 CID_154699791 | ||
| 0.262 | 0.106 | 0.347 | Immunomodulator | 0.347 0.06 CID_154699790 0.347 0.06 CID_154699791 | CID_154699791 | |
| 0.164 | 0.011 | 0.186 | Phosphodiesterase 4B inhibitor | 0.186 0.009 CID_154699790 0.186 0.009 CID_154699791 | CID_154699791 | |
| 0.326 | 0.179 | 0.326 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | |||
| 0.16 | 0.017 | 0.18 | Phosphodiesterase 4D inhibitor | 0.18 0.013 CID_154699790 0.18 0.013 CID_154699791 | CID_154699791 | |
| 0.214 | 0.081 | 0.214 | RNA-directed DNA polymerase inhibitor | 0.211 0.084 CID_154699790 0.211 0.084 CID_154699791 | ||
| 0.138 | 0.005 | 0.138 | Phosphodiesterase 1C inhibitor | 0.075 0.024 CID_154699790 0.075 0.024 CID_154699791 | ||
| 0.177 | 0.047 | 0.177 | Toll-Like receptor 9 antagonist | |||
| 0.219 | 0.09 | 0.262 | Vasodilator | 0.262 0.063 CID_154699790 0.262 0.063 CID_154699791 | CID_154699791 | |
| 0.133 | 0.019 | 0.133 | Phosphodiesterase 3A inhibitor | 0.096 0.035 CID_154699790 0.096 0.035 CID_154699791 | ||
| 0.205 | 0.093 | 0.205 | Potassium channel (Voltage-sensitive) blocker | |||
| 0.128 | 0.019 | 0.128 | Interleukin 5 antagonist | 0.111 0.03 CID_154699790 0.111 0.03 CID_154699791 | ||
| 0.125 | 0.017 | 0.13 | Adenosine A3 receptor antagonist | 0.13 0.015 CID_154699790 0.13 0.015 CID_154699791 | CID_154699791 | |
| 0.209 | 0.101 | 0.313 | Tumour necrosis factor alpha release inhibitor | 0.313 0.048 CID_154699790 0.313 0.048 CID_154699791 | CID_154699791 | |
| 0.113 | 0.009 | 0.113 | Phosphodiesterase 3B inhibitor | 0.085 0.014 CID_154699790 0.085 0.014 CID_154699791 | ||
| 0.21 | 0.108 | 0.281 | DNA synthesis inhibitor | 0.281 0.05 CID_154699790 0.281 0.05 CID_154699791 | CID_154699791 | |
| 0.106 | 0.005 | 0.106 | MAP kinase 7 inhibitor | 0.097 0.01 CID_154699790 0.097 0.01 CID_154699791 | ||
| 0.122 | 0.021 | 0.122 | HIV-1 reverse transcriptase inhibitor | 0.079 0.043 CID_154699790 0.079 0.043 CID_154699791 | ||
| 0.112 | 0.013 | 0.13 | GABA A receptor antagonist | 0.13 0.011 CID_154699790 0.13 0.011 CID_154699791 | CID_154699791 | |
| 0.149 | 0.051 | 0.187 | Interleukin 4 antagonist | 0.187 0.027 CID_154699790 0.187 0.027 CID_154699791 | CID_154699791 | |
| 0.11 | 0.014 | 0.142 | GABA receptor antagonist | 0.142 0.01 CID_154699790 0.142 0.01 CID_154699791 | CID_154699791 | |
| 0.152 | 0.058 | 0.152 | Sphingosine 1-phosphate receptor 5 antagonist | |||
| 0.09 | 0.004 | 0.091 | Parathyroid hormone antagonist | 0.091 0.004 CID_154699790 0.091 0.004 CID_154699791 | CID_154699791 | |
| 0.109 | 0.024 | 0.109 | mTOR complex 2 inhibitor | 0.094 0.04 CID_154699790 0.094 0.04 CID_154699791 | ||
| 0.117 | 0.038 | 0.117 | Acetylcholine agonist | 0.085 0.06 CID_154699790 0.085 0.06 CID_154699791 | ||
| 0.1 | 0.021 | 0.1 | Purinergic P2 antagonist | |||
| 0.104 | 0.026 | 0.104 | Adenosine A2 receptor antagonist | 0.07 0.04 CID_154699790 0.07 0.04 CID_154699791 | ||
| 0.16 | 0.084 | 0.16 | Antipruritic | 0.151 0.093 CID_154699790 0.151 0.093 CID_154699791 | ||
| 0.138 | 0.065 | 0.138 | Toll-Like receptor antagonist | |||
| 0.085 | 0.014 | 0.085 | Phosphodiesterase 1A inhibitor | |||
| 0.087 | 0.018 | 0.103 | Phosphodiesterase 4C inhibitor | 0.103 0.014 CID_154699790 0.103 0.014 CID_154699791 | CID_154699791 | |
| 0.1 | 0.032 | 0.1 | Phosphodiesterase 11A inhibitor | |||
| 0.1 | 0.032 | 0.1 | Phosphodiesterase XI inhibitor | |||
| 0.081 | 0.013 | 0.081 | Phosphodiesterase X inhibitor | 0.047 0.029 CID_154699790 0.047 0.029 CID_154699791 | ||
| 0.081 | 0.013 | 0.081 | Phosphodiesterase 10A inhibitor | 0.047 0.029 CID_154699790 0.047 0.029 CID_154699791 | ||
| 0.072 | 0.004 | 0.072 | Calcium-sensing receptor antagonist | 0.024 0.007 CID_154699790 0.024 0.007 CID_154699791 | ||
| 0.103 | 0.043 | 0.103 | Alpha 2d adrenoreceptor antagonist | |||
| 0.089 | 0.029 | 0.089 | Phosphodiesterase VI inhibitor | 0.068 0.066 CID_154699790 0.068 0.066 CID_154699791 | ||
| 0.086 | 0.027 | 0.086 | Phosphodiesterase VIII inhibitor | 0.074 0.046 CID_154699790 0.074 0.046 CID_154699791 | ||
| 0.065 | 0.005 | 0.065 | Phosphodiesterase 6C inhibitor | 0.055 0.014 CID_154699790 0.055 0.014 CID_154699791 | ||
| 0.063 | 0.005 | 0.063 | Angiotensin AT1 receptor antagonist | 0.039 0.036 CID_154699790 0.039 0.036 CID_154699791 | ||
| 0.152 | 0.098 | 0.154 | Tumour necrosis factor antagonist | 0.154 0.096 CID_154699790 0.154 0.096 CID_154699791 | CID_154699791 | |
| 0.091 | 0.038 | 0.091 | Interferon agonist | 0.082 0.048 CID_154699790 0.082 0.048 CID_154699791 | ||
| 0.057 | 0.005 | 0.057 | Angiotensin II receptor antagonist | |||
| 0.083 | 0.03 | 0.083 | Adenosine A2a receptor antagonist | 0.066 0.039 CID_154699790 0.066 0.039 CID_154699791 | ||
| 0.074 | 0.023 | 0.082 | Phosphodiesterase 4A inhibitor | 0.082 0.02 CID_154699790 0.082 0.02 CID_154699791 | CID_154699791 | |
| 0.152 | 0.102 | 0.248 | Lipocortins synthesis antagonist | 0.248 0.034 CID_154699790 0.248 0.034 CID_154699791 | CID_154699791 | |
| 0.102 | 0.054 | 0.102 | Phosphodiesterase 7B inhibitor | |||
| 0.076 | 0.028 | 0.076 | Interferon inducer | 0.07 0.035 CID_154699790 0.07 0.035 CID_154699791 | ||
| 0.103 | 0.056 | 0.103 | mTOR complex 1 inhibitor | 0.097 0.069 CID_154699790 0.097 0.069 CID_154699791 | ||
| 0.068 | 0.025 | 0.068 | Phosphodiesterase II inhibitor | 0.052 0.044 CID_154699790 0.052 0.044 CID_154699791 | ||
| 0.064 | 0.024 | 0.064 | Histamine agonist | |||
| 0.125 | 0.085 | 0.125 | Ribosomal protein S6 kinase inhibitor | |||
| 0.059 | 0.02 | 0.059 | Histamine H4 receptor antagonist | |||
| 0.113 | 0.075 | 0.113 | Transcription factor STAT6 inhibitor | |||
| 0.096 | 0.062 | 0.096 | DNA directed RNA polymerase inhibitor | |||
| 0.043 | 0.009 | 0.043 | Phosphodiesterase 6B inhibitor | 0.031 0.02 CID_154699790 0.031 0.02 CID_154699791 | ||
| 0.058 | 0.025 | 0.058 | Phosphodiesterase 2A inhibitor | |||
| 0.129 | 0.097 | 0.129 | Acetylcholine M1 receptor antagonist | 0.121 0.106 CID_154699790 0.121 0.106 CID_154699791 | ||
| 0.056 | 0.027 | 0.056 | Purinergic P2X antagonist | |||
| 0.121 | 0.094 | 0.121 | Nav1.6 sodium channel blocker | |||
| 0.153 | 0.128 | 0.153 | HERG channel blocker | |||
| 0.057 | 0.031 | 0.06 | Autotaxin inhibitor | 0.06 0.028 CID_154699790 0.06 0.028 CID_154699791 | CID_154699791 | |
| 0.075 | 0.051 | 0.075 | Acetylcholine M4 receptor antagonist | |||
| 0.086 | 0.062 | 0.086 | Bromodomain-containing protein 2 inhibitor | |||
| 0.07 | 0.047 | 0.07 | Toll-Like receptor 7 antagonist | |||
| 0.029 | 0.007 | 0.029 | Phosphodiesterase 6A inhibitor | 0.024 0.014 CID_154699790 0.024 0.014 CID_154699791 | ||
| 0.025 | 0.004 | 0.025 | Prokineticin receptor 1 antagonist | 0.02 0.006 CID_154699790 0.02 0.006 CID_154699791 | ||
| 0.037 | 0.017 | 0.037 | Acetylcholine M4 receptor agonist | |||
| 0.029 | 0.009 | 0.029 | Phosphodiesterase 6H inhibitor | |||
| 0.029 | 0.009 | 0.029 | Phosphodiesterase 6G inhibitor | |||
| 0.062 | 0.043 | 0.062 | Dopamine D3 antagonist | |||
| 0.078 | 0.059 | 0.078 | Histamine H1 receptor antagonist | |||
| 0.142 | 0.124 | 0.142 | Psychostimulant | |||
| 0.055 | 0.038 | 0.055 | Acetylcholine muscarinic agonist | 0.049 0.044 CID_154699790 0.049 0.044 CID_154699791 | ||
| 0.056 | 0.041 | 0.056 | 5 Hydroxytryptamine 3 antagonist | |||
| 0.09 | 0.076 | 0.09 | Phosphodiesterase 6D inhibitor | |||
| 0.05 | 0.038 | 0.05 | mTOR inhibitor | |||
| 0.035 | 0.023 | 0.035 | Purinergic P2X3 antagonist | |||
| 0.048 | 0.036 | 0.048 | Adenosine A2b receptor antagonist | |||
| 0.194 | 0.184 | 0.194 | Ca2+/calmodulin-dependent kinase IV inhibitor | |||
| 0.089 | 0.082 | 0.089 | Nav1.1 sodium channel blocker | |||
| 0.138 | 0.133 | 0.177 | Non-steroidal antiinflammatory agent | 0.177 0.09 CID_154699790 0.177 0.09 CID_154699791 | CID_154699791 | |
| 0.076 | 0.072 | 0.076 | Alpha 2 adrenoreceptor antagonist | |||
| 0.033 | 0.03 | 0.033 | Adenosine uptake inhibitor | |||
| 0.013 | 0.01 | 0.013 | Angiotensin AT1B receptor antagonist | |||
| 0.037 | 0.035 | 0.037 | Dopamine D5 antagonist | |||
| 0.02 | 0.018 | 0.02 | Integrin alphaVbeta3 antagonist | |||
| 0.068 | 0.075 | 0.076 | Acetylcholine M3 receptor agonist | 0.076 0.065 CID_154699790 0.076 0.065 CID_154699791 | CID_154699791 | |
| 0.225 | 0.241 | 0.37 | Cyclophilin D inhibitor | 0.37 0.109 CID_154699790 0.37 0.109 CID_154699791 | CID_154699791 | |
| 0.029 | 0.064 | 0.05 | Glucose-6-phosphate dehydrogenase inhibitor | 0.05 0.012 CID_154699790 0.05 0.012 CID_154699791 | CID_154699791 | |
| 0.128 | 0.187 | 0.159 | Spasmolytic | 0.159 0.155 CID_154699790 0.159 0.155 CID_154699791 | CID_154699791 | |
| 0.015 | 0.075 | 0.02 | Vitamin D receptor antagonist | 0.02 0.019 CID_154699790 0.02 0.019 CID_154699791 | CID_154699791 | |
| 0.009 | 0.074 | 0.033 | RNA-directed RNA polymerase stimulant | 0.033 0.02 CID_154699790 0.033 0.02 CID_154699791 | CID_154699791 | |
| 0.148 | 0.227 | 0.324 | Cholesterol antagonist | 0.324 0.077 CID_154699790 0.324 0.077 CID_154699791 | CID_154699791 | |
| 0.062 | 0.146 | 0.111 | Anabolic | 0.111 0.049 CID_154699790 0.111 0.049 CID_154699791 | CID_154699791 | |
| 0.015 | 0.106 | 0.037 | HMG CoA reductase inhibitor | 0.037 0.018 CID_154699790 0.037 0.018 CID_154699791 | CID_154699791 | |
| 0.095 | 0.19 | 0.223 | Anesthetic general | 0.223 0.063 CID_154699790 0.223 0.063 CID_154699791 | CID_154699791 | |
| 0.148 | 0.244 | 0.206 | Vasodilator, coronary | 0.206 0.176 CID_154699790 0.206 0.176 CID_154699791 | CID_154699791 | |
| 0.029 | 0.129 | 0.066 | Androgen agonist | 0.066 0.034 CID_154699790 0.066 0.034 CID_154699791 | CID_154699791 | |
| 0.106 | 0.222 | 0.164 | Neurotrophic factor enhancer | 0.164 0.118 CID_154699790 0.164 0.118 CID_154699791 | CID_154699791 | |
| 0.097 | 0.218 | 0.125 | Pregnane X receptor agonist | 0.125 0.115 CID_154699790 0.125 0.115 CID_154699791 | CID_154699791 | |
| 0.137 | 0.265 | 0.198 | Vasodilator, peripheral | 0.198 0.179 CID_154699790 0.198 0.179 CID_154699791 | CID_154699791 | |
| 0.084 | 0.241 | 0.124 | Adenylate cyclase stimulant | 0.124 0.116 CID_154699790 0.124 0.116 CID_154699791 | CID_154699791 | |
| 0.132 | 0.303 | 0.207 | Antiobesity | 0.207 0.2 CID_154699790 0.207 0.2 CID_154699791 | CID_154699791 | |
| 0.183 | 0.358 | 0.38 | Antiinflammatory | 0.38 0.152 CID_154699790 0.38 0.152 CID_154699791 | CID_154699791 | |
| 0.121 | 0.301 | 0.2 | Antithrombotic | 0.2 0.178 CID_154699790 0.2 0.178 CID_154699791 | CID_154699791 | |
| 0.04 | 0.231 | 0.098 | Cholesterol synthesis inhibitor | 0.098 0.091 CID_154699790 0.098 0.091 CID_154699791 | CID_154699791 | |
| 0.093 | 0.411 | 0.36 | Sodium/bile acid cotransporter inhibitor | 0.36 0.034 CID_154699790 0.36 0.034 CID_154699791 | CID_154699791 | |
| 0.045 | 0.372 | 0.17 | Hypolipemic | 0.17 0.118 CID_154699790 0.17 0.118 CID_154699791 | CID_154699791 | |
| 0.052 | 0.422 | 0.145 | Hepatoprotectant | 0.145 0.115 CID_154699790 0.145 0.115 CID_154699791 | CID_154699791 | |
| 0.089 | 0.514 | 0.189 | Peptidyltransferase inhibitor | 0.189 0.114 CID_154699790 0.189 0.114 CID_154699791 | CID_154699791 | |
| 0.074 | 0.635 | 0.221 | Interleukin 2 agonist | 0.221 0.155 CID_154699790 0.221 0.155 CID_154699791 | CID_154699791 | |
| 0.023 | 0.589 | 0.118 | Farnesoid X receptor antagonist | 0.118 0.109 CID_154699790 0.118 0.109 CID_154699791 | CID_154699791 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |